The COVID-19 pandemic has brought the world literally to a standstill. Council of Scientific and Industrial Research (CSIR), India through its 38 laboratories and expertise in diverse areas ranging from aerospace to buildings to genomics to chemicals, quickly sprang into action developing COVID-19 interventions. For effective planning and strategizing, CSIR, India swiftly set up five COVID-19 verticals including disease surveillance, drugs & vaccines, testing & diagnostics, PPEs and supply chain management. CSIR, India's rich R&D knowledgebase is embodied in the rapid testing, cost-effective diagnostic kits, virus culture, genome sequencing and disease surveillance. With the perfect blend of scientific knowledge, technical expertise, industry linkages and governmental interfaces, through innovations and improvisations CSIR, India has come up with many technologies and products to be deployed against COVID-19. Dry Swab Based Diagnostic for COVID-19 detection. Dry Swab-based Method helps in easier transportation &  sample handling. Sample is collected as dry swabs (with nasopharyngeal samples on it) TE buffer is used to isolate the biological samples, skip RNA isolation, and proceed with RT-qPCR without compromising the sensitivity of the COVID-19 tests. It: Saves time and Cost and has been validated by independent research labs in India. We eagerly look forward to partnering with R&D organizations and industries from around the world to take this technology to the people.